FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280558977> ?p ?o ?g. }

• W4280558977 abstract "Jian-Pi-Yi-Shen formula (JPYSF), a traditional Chinese medicine, has been recommended to treat renal fibrosis for decades. Previous studies had shown that JPYSF could inhibit epithelial-mesenchymal transition (EMT), an important regulatory role in renal fibrosis. However, the mechanism of JPYSF action is largely unknown. In this study, network pharmacology and experimental verification were combined to elucidate and identify the potential mechanism of JPYSF against renal fibrosis by suppressing EMT at molecular and pathway levels. Network pharmacology was first performed to explore the mechanism of JPYSF against renal fibrosis targeting EMT, and then a 5/6 nephrectomy (5/6 Nx)-induced rat model of renal fibrosis was selected to verify the predictive results by Masson's trichrome stains and western blot analysis. Two hundred and thirty-two compounds in JPYSF were selected for the network approach analysis, which identified 137 candidate targets of JPYSF and 4,796 known therapeutic targets of EMT. The results of the Gene Ontology (GO) function enrichment analysis included 2098, 88, and 133 GO terms for biological processes (BPs), molecular functions (MFs), and cell component entries, respectively. The top 10 enrichment items of BP annotations included a response to a steroid hormone, a metal ion, oxygen levels, and so on. Cellular composition (CC) is mainly enriched in membrane raft, membrane microdomain, membrane region, etc. The MF of JPYSF analysis on EMT was predominately involved in proximal promoter sequence-specific DNA binding, protein heterodimerization activity, RNA polymerase II proximal promoter sequence-specific DNA binding, and so on. The involvement signaling pathway of JPYSF in the treatment of renal fibrosis targeting EMT was associated with anti-fibrosis, anti-inflammation, podocyte protection, and metabolism regulation. Furthermore, the in vivo experiments confirmed that JPYSF effectively ameliorated interstitial fibrosis and inhibited the overexpression of α-SMA, Wnt3a, and β-catenin, and increased the expression of E-cadherin by wnt3a/β-catenin signaling pathway in 5/6 Nx-induced renal fibrosis rats. Using an integrative network pharmacology-based approach and experimental verification, the study showed that JPYSF had therapeutic effects on EMT by regulating multi-pathway, among which one proven pathway was the Wnt3a/β-catenin signaling pathway. These findings provide insights into the renoprotective effects of JPYSF against EMT, which could suggest directions for further research of JPYSF in attenuating renal fibrosis by suppressing EMT." @default.
• W4280558977 created "2022-05-22" @default.
• W4280558977 creator A5007674773 @default.
• W4280558977 creator A5011829652 @default.
• W4280558977 creator A5017456524 @default.
• W4280558977 creator A5047899405 @default.
• W4280558977 creator A5073861665 @default.
• W4280558977 creator A5082845640 @default.
• W4280558977 creator A5084018381 @default.
• W4280558977 date "2022-05-17" @default.
• W4280558977 modified "2023-09-30" @default.
• W4280558977 title "Network Pharmacology and Experimental Verification Strategies to Illustrate the Mechanism of Jian-Pi-Yi-Shen Formula in Suppressing Epithelial–Mesenchymal Transition" @default.
• W4280558977 cites W2149711855 @default.
• W4280558977 cites W2469556791 @default.
• W4280558977 cites W2884761100 @default.
• W4280558977 cites W2898468989 @default.
• W4280558977 cites W2901527454 @default.
• W4280558977 cites W2905701680 @default.
• W4280558977 cites W2914774496 @default.
• W4280558977 cites W2920012291 @default.
• W4280558977 cites W2947780998 @default.
• W4280558977 cites W2969248504 @default.
• W4280558977 cites W3008078377 @default.
• W4280558977 cites W3015939024 @default.
• W4280558977 cites W3021555064 @default.
• W4280558977 cites W3028356505 @default.
• W4280558977 cites W3031003193 @default.
• W4280558977 cites W3033256098 @default.
• W4280558977 cites W3040665781 @default.
• W4280558977 cites W3081774813 @default.
• W4280558977 cites W3092922824 @default.
• W4280558977 cites W3111642931 @default.
• W4280558977 cites W3121337579 @default.
• W4280558977 cites W3136753862 @default.
• W4280558977 cites W3157458659 @default.
• W4280558977 cites W3160638454 @default.
• W4280558977 cites W3167853195 @default.
• W4280558977 cites W3188278162 @default.
• W4280558977 cites W3190737547 @default.
• W4280558977 cites W3193850084 @default.
• W4280558977 cites W3194278424 @default.
• W4280558977 cites W3200259006 @default.
• W4280558977 cites W3204408343 @default.
• W4280558977 cites W3207520509 @default.
• W4280558977 doi "https://doi.org/10.3389/fphar.2022.873023" @default.
• W4280558977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35656312" @default.
• W4280558977 hasPublicationYear "2022" @default.
• W4280558977 type Work @default.
• W4280558977 citedByCount "3" @default.
• W4280558977 countsByYear W42805589772022 @default.
• W4280558977 crossrefType "journal-article" @default.
• W4280558977 hasAuthorship W4280558977A5007674773 @default.
• W4280558977 hasAuthorship W4280558977A5011829652 @default.
• W4280558977 hasAuthorship W4280558977A5017456524 @default.
• W4280558977 hasAuthorship W4280558977A5047899405 @default.
• W4280558977 hasAuthorship W4280558977A5073861665 @default.
• W4280558977 hasAuthorship W4280558977A5082845640 @default.
• W4280558977 hasAuthorship W4280558977A5084018381 @default.
• W4280558977 hasBestOaLocation W42805589771 @default.
• W4280558977 hasConcept C104317684 @default.
• W4280558977 hasConcept C142724271 @default.
• W4280558977 hasConcept C185592680 @default.
• W4280558977 hasConcept C194232998 @default.
• W4280558977 hasConcept C2776415932 @default.
• W4280558977 hasConcept C2780559512 @default.
• W4280558977 hasConcept C502942594 @default.
• W4280558977 hasConcept C55493867 @default.
• W4280558977 hasConcept C71924100 @default.
• W4280558977 hasConcept C76419328 @default.
• W4280558977 hasConcept C86803240 @default.
• W4280558977 hasConcept C95444343 @default.
• W4280558977 hasConcept C98274493 @default.
• W4280558977 hasConceptScore W4280558977C104317684 @default.
• W4280558977 hasConceptScore W4280558977C142724271 @default.
• W4280558977 hasConceptScore W4280558977C185592680 @default.
• W4280558977 hasConceptScore W4280558977C194232998 @default.
• W4280558977 hasConceptScore W4280558977C2776415932 @default.
• W4280558977 hasConceptScore W4280558977C2780559512 @default.
• W4280558977 hasConceptScore W4280558977C502942594 @default.
• W4280558977 hasConceptScore W4280558977C55493867 @default.
• W4280558977 hasConceptScore W4280558977C71924100 @default.
• W4280558977 hasConceptScore W4280558977C76419328 @default.
• W4280558977 hasConceptScore W4280558977C86803240 @default.
• W4280558977 hasConceptScore W4280558977C95444343 @default.
• W4280558977 hasConceptScore W4280558977C98274493 @default.
• W4280558977 hasFunder F4320321001 @default.
• W4280558977 hasLocation W42805589771 @default.
• W4280558977 hasLocation W42805589772 @default.
• W4280558977 hasLocation W42805589773 @default.
• W4280558977 hasOpenAccess W4280558977 @default.
• W4280558977 hasPrimaryLocation W42805589771 @default.
• W4280558977 hasRelatedWork W2032942532 @default.
• W4280558977 hasRelatedWork W2079500029 @default.
• W4280558977 hasRelatedWork W2193392580 @default.
• W4280558977 hasRelatedWork W2479066576 @default.
• W4280558977 hasRelatedWork W2745208420 @default.
• W4280558977 hasRelatedWork W2809828786 @default.
• W4280558977 hasRelatedWork W3022892502 @default.
• W4280558977 hasRelatedWork W3024827208 @default.
• W4280558977 hasRelatedWork W3117344389 @default.

• next